Table 1.
Patient characteristics
| Patient, no. | Age [years] | PSA [μg/L] | PSA doubling time [months] | Indication Gleason |
Activity [MBq] | Activity/weight [MBq/kg] | Local PSMA+ | Nodal PSMA+ | Distant PSMA+ | Therapeutic consequence |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 76 | 1.48 ADT | 8 |
RT, ADT. Intensification of the ADT? 4 + 4 |
363 | 4.78 | Right prostate | 0 | Sternum | RT prostate. No intensification of the ADT |
| 2 | 67 | 0.7 | 9 |
BCR after prostatectomy 4 + 3 |
355 | 4.03 | 0 | 2 LNs left iliacal | 0 | RT LNs |
| 3 | 66 | 1.03 | > 12 |
BCR after prostatectomy and RT 4 + 3 |
347 | 3.62 | 0 | 0 | 0 | Wait and see |
| 4 | 74 | 1.1 | 4 |
BCR after prostatectomy 3 + 4 |
350 | 4.73 | 0 | 1 LN left iliacal | 0 | S-LAD and RT LN |
| 5 | 63 | 4.7 | n.a. |
BCR after prostatectomy. 4 + 3 |
329 | 3.78 | Right prostate | 0 | 0 | RT prostate fossa |
| 6 | 64 |
130.0 ADT |
3 |
Prostatectomy, ADT. Planning local intervention? n.a. |
384 | 3.96 | Right prostate |
2 LNs pre-sacral 1 LN right iliacal |
> 5 osseous lesions | No cystectomy |
| 7 | 52 | 14.9 | > 12 |
BCR after prostatectomy and RT 3 + 3 |
370 | 4.30 | 0 | 0 | 0 | Wait and see |
| 8 | 73 | 0.8 | 5 |
BCR after prostatectomy 4 + 3 |
371 | 4.95 | 0 | 3 LNs retroperitoneal | 0 | RT LNs |
| 9 | 74 | 1.02 | > 12 |
BCR after prostatectomy 3 + 4 |
379 | 4.6 | 0 | 0 | 0 | Wait and see |
| 10 | 59 | 0.51 | n.a. |
BCR after prostatectomy 4 + 3 |
345 | 3.45 | 0 | 0 | 0 | RT prostate fossa |
ADT androgen deprivation therapy, BCR biochemical recurrence, LAD lymphadenectomy, LN lymph node, n.a. not available, RT radiotherapy, S-LAD salvage lymphadenectomy